Yuvical-D Capsule contains Calcium Dobesilate 500 mg, a vasoactive agent primarily used to improve microcirculation and vascular health. It is indicated for the treatment of chronic venous insufficiency, diabetic retinopathy, and hemorrhoidal disease by enhancing capillary permeability and reducing capillary fragility. Calcium Dobesilate acts by stabilizing the basement membrane of blood vessels, thereby preventing leakage and improving blood flow in affected tissues. This mechanism contributes to the reduction of edema, inflammation, and oxidative stress associated with microvascular disorders. Yuvical-D is commonly prescribed to alleviate symptoms such as leg heaviness, pain, swelling, and visual disturbances related to diabetic retinopathy. The capsule is administered orally, with the dosage and duration tailored according to the severity of the condition and patient response. It is generally well-tolerated; however, patients should be monitored for potential adverse effects such as gastrointestinal discomfort or allergic reactions. Yuvical-D should be used with caution in individuals with known hypersensitivity to Calcium Dobesilate or any capsule components. It is essential to follow the prescribing physician’s instructions and avoid self-medication. This medication should be stored in a cool, dry place away from direct sunlight and out of reach of children.